IBIO

Value Q3, 24Q4, 24Q1, 25Q2, 25 TTM Total revenue 0200 K100 K0 300 K Gross profit 0200 K100 K0 300 K Operating expenses 4.88 M5.4 M6.05 M9.45 M 25.77 M Selling/general/admin expenses 2.97 M2.17 M2.5 M5.17 M 12.81 M Research & development 1.91 M3.22 M3.55 M4.28 M 12.96 M Operating income 4.88 M5.2 M5.95 M9.45 M 25.47 M Non-Operating Income, Total 18 K35 K231 K452 K 736 K Interest expense, net of interest capitalized 54 K44 K36 K41 K 175 K Non-Operating Income, excl. Interest Expenses -36 K-9 000195 K411 K 561 K Unusual income/expense ———— — Pretax income 4.84 M5.19 M6.15 M9.86 M 26.03 M Equity in earnings ———— — Taxes 0000 0 Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 4.32 M631 K5.72 M8.99 M 19.67 M Discontinued operations 537 K4.53 M—— — Net income 4.86 M5.16 M5.72 M8.99 M 24.74 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 4.86 M5.16 M5.67 M8.99 M 24.69 M Basic earnings per share (Basic EPS) -0.49-0.32-0.11-0.09 -1.01 Diluted earnings per share (Diluted EPS) -0.49-0.32-0.11-0.09 -1.01 Average basic shares outstanding 9.86 M10.5 M52.98 M99.13 M 172.47 M Diluted shares outstanding 9.86 M10.5 M52.98 M99.13 M 172.47 M EBITDA ———— — EBIT ———— — Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 193 K209 K9.19 M146 K 9.73 M